Related Experiment Video
Updated: May 20, 2025
06:43
Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model
Published on: October 9, 2018
9.5K
In Utero Therapies, the Next Frontier
Teodora R Kolarova1, Edith Cheng1,2
1Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.
Summary
Targeted in utero therapies offer new hope for genetic conditions by correcting disease mechanisms before birth. Further research into fetal development and ethical considerations is crucial for advancing these prenatal treatments.
Area of Science:
- Medical Genetics
- Developmental Biology
- Immunology
Background:
- Molecular diagnostics and genetic understanding have driven targeted therapies.
- Prenatal diagnosis has evolved, with growing interest in in utero interventions.
- Preventing irreversible fetal injury and optimizing treatment efficacy are key goals.
Purpose of the Study:
- To review current in utero targeted fetal therapies.
- To explore the history and ethical dimensions of fetal interventions.
- To highlight areas for future research in prenatal treatment.
Main Methods:
- Literature review of advancements in molecular diagnostics.
- Analysis of research on in utero interventions and fetal physiology.
- Examination of social and ethical implications of fetal therapy.
Main Results:
- Targeted therapies are emerging for genetic conditions.
- In utero interventions aim to correct disease mechanisms prenatally.
- Significant research is ongoing, with promising trials.
Conclusions:
- Refining in utero therapies requires deeper understanding of fetal immunology and development.
- Social and ethical considerations, including reproductive autonomy, are paramount.
- Continued research and ethical discourse are essential for advancing fetal medicine.
